1 |
Beral, V., Banks, E., Reeves, G., and Appleby, P., Use of HRT and the subsequent risk of cancer. J. Epidemiol. Biostat., 4, 191-215 (1999)
|
2 |
Brownson, D. M., Azios, N. G., Fuqua, B. K., Dharmawardhane, S. F., and Mabry, T. J., Flavonoid effects relevant to cancer. J. Nutr., 132, 3482S-3489S (2002)
DOI
|
3 |
Joo, S. S., Won, T. J., Kang, H. C., and Lee, D. I., Isoflavones extracted from Sophorae fructus upregulate IGF-1 and TGF- and inhibit osteoclastogenesis in rat bone marrow cells. Arch. Pharm. Res., 27, 99-105 (2004)
DOI
ScienceOn
|
4 |
Kuiper, G., Lemmen, J., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., and Gustafsson, J. A., Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139, 4252-4264 (1998)
DOI
ScienceOn
|
5 |
Teresa, C., Cohick, W., and Raskin, I., Dietary phytoestrogens and health. Phytochemistry, 65, 995-1016 (2004)
DOI
ScienceOn
|
6 |
Wuttke, W., Jarry, H., Becker, T., Schultens, A., Christoffel, V., Gorkow, C., and Seidlova-Wuttke, D., Phytoestrogens: endocrine disruptors or replacement for hormone replacement therapy? Maturitas, 44, S9-S20 (2003)
DOI
ScienceOn
|
7 |
Cassidy, A., Bingham, S., and Setchell, K. D., Biologic effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am. J. Clin. Nutr., 60, 333-340 (1994)
DOI
|
8 |
Fitzpatric, L. A., Soy isoflavones: hope or hype? Maturitas, 44, 21-29 (2003)
DOI
ScienceOn
|
9 |
Kronenberg, F. and Fugh-Berman, A., Complementary and alternative medicine for menopausal systems: a review of randomized, controlled trials. Ann. Intern. Med., 137, 805- 813 (2002)
DOI
ScienceOn
|
10 |
Adlercreutz, H., Epidemiology of phytoestrogens. Baillieres Clin. Endocrinol. Metab., 12, 605-623 (1998)
DOI
PUBMED
ScienceOn
|
11 |
Kang, H. J., Ansbacher, R., and Hammoud, M. M., Use of alternative and complementary medicine in menopause. Intern. J. Gynecol. Obstet., 79, 195-207 (2002)
DOI
ScienceOn
|
12 |
Tavani, A. and La Vecchia, C., The adverse effects of hormone replacement therapy. Drugs Aging, 14, 347-357 (1999)
DOI
ScienceOn
|
13 |
Steer, T. E., Johnson, I. T., Gee, J. M., and Gibson, G.. R., Metabolism of the soybean isoflavone glycoside genistin in vitro by human gut bacteria and the effect of prebiotics. Br. J. Nutr., 90, 635-642 (2003)
DOI
ScienceOn
|
14 |
Greendale, G. A., Reboussin, B. A., Hogan, P., Barnabei, V. M., Shumaker, S., and Barrett-Connor, E., Symptom relief and side effects of postmenopausal hormone results from the postmenopausal estrogen/progestin interventions trial. Obstet. Gynecol., 92, 982-988 (1998)
DOI
ScienceOn
|
15 |
Greendale, G. A., Lee, N. P., and Arriola, E. R., The menopause. Lancet, 353, 571-580 (1999)
DOI
ScienceOn
|
16 |
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., Stefanick, M. L., Gass, M., Lane, D., Rodabough, R. J., Gilligan, M. A., Cyr, M. G., Thomson, C. A., Khandekar, J., Petrovitch, H., and McTiernan, A., Influence of estrogen plus progesterone on breast cancer and mammography in healthy postmenopausal women. JAMA, 289, 3243-3253 (2003)
DOI
ScienceOn
|
17 |
Joo, S. S., Won, T. J., and Lee, D. I., Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2). Arch. Pharm. Res., 27, 954-960 (2004)
DOI
ScienceOn
|